Cancer Family
Malignant Digestive System Neoplasm
CI-CAN-00000229Explore in graph →
4,262 active trials43 approved drugs556 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000229Explore in graph →
Clinical trials
19,108 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (2,001)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01063192 | A Study of Locally Advanced Pancreatic Cancer | unknown | Phase 2 | 73 | National Health Research Institutes, TaiwanOTHER | 0 | Feb 5, 2010 | clinicaltrials |
| NCT00274872 | Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery | unknown | Phase 2 / Phase 3 | 600 | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Feb 1, 2010 |
| NCT00568971 | Study of Weekly DCF to Treat Advanced Gastric Cancer | terminated | Phase 2 | 40 | Fudan UniversityOTHER | 1 | Jan 27, 2010 | clinicaltrials |
| NCT00251186 | First-Line Capecitabine and Cetuximab for Metastatic Colorectal Ca in Elderly Patients | terminated | Phase 2 | 18 | University of Medicine and Dentistry of New JerseyOTHER | 1 | Jan 26, 2010 | clinicaltrials |
| NCT01055743 | The Effect of Fluorouracil Implants Regional Chemotherapy During the Surgical Treatment for Early Stage Hepatocellular Carcinoma | unknown | Phase 2 | 250 | Simcere Pharmaceutical Co., LtdOTHER | 1 | Jan 26, 2010 | clinicaltrials |
| NCT00230451 | Pre-operative Chemotherapy and Radiation Therapy for Esophageal Carcinoma | completed | Phase 2 | — | University of Michigan Rogel Cancer CenterOTHER | 1 | Jan 15, 2010 | clinicaltrials |
| NCT00285701 | Early Detection of Polyps and Colon Cancer by Fluorescence Imaging - a Dose-finding Study | completed | Phase 1 / Phase 2 | 38 | PhotocureINDUSTRY | 1 | Jan 15, 2010 | clinicaltrials |
| NCT00743964 | Phase II Study of Epirubicin, Cisplatin and Capecitabine (ECX) Versus Cisplatin and Capecitabine (CX) for Advanced Gastric Cancer (AGC) | completed | Phase 2 | 91 | Samsung Medical CenterOTHER | 1 | Jan 15, 2010 | clinicaltrials |
| NCT00383695 | Oxaliplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients Undergoing Surgery for High-Risk Rectal Cancer(EXPERT-C) | unknown | Phase 2 | 164 | Royal Marsden NHS Foundation TrustOTHER | 3 | Jan 13, 2010 | clinicaltrials |
| NCT00744640 | Gemcitabine, Oxaliplatin and Capecitabine for Advanced Pancreatic Carcinoma(GEMOXEL) | completed | Phase 1 / Phase 2 | 46 | University Hospital, Basel, SwitzerlandOTHER | 1 | Jan 12, 2010 | clinicaltrials |
| NCT00220116 | Phase II Trial Assessing Efficacy and Toxicity of Capecitabine and Oxaliplatin in the Treatment of Colorectal Cancer | completed | Phase 2 | 172 | Royal Marsden NHS Foundation TrustOTHER | 1 | Jan 6, 2010 | clinicaltrials |
| NCT00677287 | Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer | terminated | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | Dec 29, 2009 | clinicaltrials |
| NCT00677612 | Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer | terminated | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | Dec 29, 2009 | clinicaltrials |
| NCT01039181 | Calcitriol in Advanced Intrahepatic Cholangiocarcinoma | unknown | Phase 2 | 28 | National Science and Technology Development Agency, ThailandOTHER_GOV | 1 | Dec 24, 2009 | clinicaltrials |
| NCT00699881 | Study of Cetuximab to Treat Gastric Cancer(STAGE) | completed | Phase 2 | 61 | Fudan UniversityOTHER | 1 | Dec 23, 2009 | clinicaltrials |
| NCT01034332 | Paclitaxel/Cisplatin/Fluorouracil Followed by Paclitaxel/Cisplatin/Radiotherapy and Esophagectomy for Esophageal Cancer | unknown | Phase 2 | 58 | National Taiwan University HospitalOTHER | 1 | Dec 18, 2009 | clinicaltrials |
| NCT01034189 | Cetuximab/Paclitaxel/Cisplatin Concurrent Chemoradiotherapy Followed by Esophagectomy for Loco-regional Esophageal Cancer | unknown | Phase 2 | 62 | National Taiwan University HospitalOTHER | 1 | Dec 17, 2009 | clinicaltrials |
| NCT00220155 | Phase II Fixed Dose Rate Gemcitabine for Advanced or Metastatic Colorectal Cancer | completed | Phase 2 | 16 | Royal Marsden NHS Foundation TrustOTHER | 1 | Dec 16, 2009 | clinicaltrials |
| NCT00066716 | Celecoxib, Paclitaxel, and Carboplatin in Treating Patients With Cancer of the Esophagus | completed | Phase 2 | 39 | Weill Medical College of Cornell UniversityOTHER | 1 | Dec 8, 2009 | clinicaltrials |
| NCT00020930 | Cetuximab in Treating Patients With Stage IV Colorectal Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 4, 2009 | clinicaltrials |
| NCT00380588 | Randomized Phase 2 Study With Gemcitabine Alone and Combination Therapy for Patients With Advanced Biliary Tract Cancer | completed | Phase 2 | 84 | Eli Lilly and CompanyINDUSTRY | 1 | Nov 20, 2009 | clinicaltrials |
| NCT00681252 | Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer | completed | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | Nov 19, 2009 | clinicaltrials |
| NCT00681330 | Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer | completed | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | Nov 19, 2009 | clinicaltrials |
| NCT00681421 | Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer | completed | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | Nov 19, 2009 | clinicaltrials |
| NCT00681577 | Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer | completed | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | Nov 19, 2009 | clinicaltrials |
| NCT00344552 | Phase II Study of Weekly Paclitaxel (BMS-181339)in Patients With Advanced or Recurrent Esophageal Cancer | completed | Phase 2 | 53 | Bristol-Myers SquibbINDUSTRY | 1 | Nov 13, 2009 | clinicaltrials |
| NCT00125021 | Tarceva and Capecitabine for Pancreatic Cancer | completed | Phase 2 | 32 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 2, 2009 | clinicaltrials |
| NCT00137761 | Docetaxel in Combination With Iressa in Previously Treated Patients With Pancreatic Cancer | completed | Phase 2 | 32 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 2, 2009 | clinicaltrials |
| NCT00165568 | Using Positron Emission Tomography to Evaluate the Effects of Bevacizumab on Intra-tumoral Pharmacokinetics of 5-fluorouracil in Metastatic Colorectal Cancer | completed | Phase 2 | 20 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 2, 2009 | clinicaltrials |
| NCT00006117 | Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 2 | Oct 30, 2009 | clinicaltrials |
| NCT01002443 | Efficacy Study of Helicobacter Pylori Eradication in Patients Undergoing Subtotal Gastrectomy for Gastric Cancer | completed | Phase 2 | 190 | National Cancer Center, KoreaOTHER_GOV | 1 | Oct 27, 2009 | clinicaltrials |
| NCT00999843 | Safety Study of Sorafenib Following Combined Therapy of Radiation and TACE for Liver Cancer | unknown | Phase 1 / Phase 2 | 30 | Fudan UniversityOTHER | 1 | Oct 22, 2009 | clinicaltrials |
| NCT00997685 | Evaluate Efficacy and Safety of XELOX in Potentially Resectable Liver Metastasis From Colorectal Cancer(CRC) | unknown | Phase 2 | 110 | Guangdong Provincial People's HospitalOTHER | 1 | Oct 19, 2009 | clinicaltrials |
| NCT00399750 | TREE-2: Three Regimens of Eloxatin in Advanced Colorectal Cancer | completed | Phase 2 | 373 | SanofiINDUSTRY | 1 | Oct 15, 2009 | clinicaltrials |
| NCT00995358 | A Study With Peptide Vaccination in Treating Patients With Esophageal Cancer | unknown | Phase 2 | 60 | University of YamanashiOTHER | 1 | Oct 15, 2009 | clinicaltrials |
| NCT00447967 | Combination of CPT-11 and LoHP vs Combination of 5-FU, Leucovorin and LoHP as 1st Line Treatment in Gastric Patients | completed | Phase 2 | 110 | Hellenic Oncology Research GroupOTHER | 1 | Sep 28, 2009 | clinicaltrials |
| NCT00980603 | Docetaxel Versus Docetaxel Plus Cisplatin Versus Docetaxel Plus S-1 as Second-line Chemotherapy in Metastatic Gastric Cancer | unknown | Phase 2 | 144 | National Cancer Center, KoreaOTHER_GOV | 1 | Sep 21, 2009 | clinicaltrials |
| NCT00625573 | Phase II Trial of Abraxane and Capecitabine in Metastatic Colon Cancer (COL 01)(ABX067) | completed | Phase 2 | 29 | Mt. Sinai Medical Center, MiamiOTHER | 1 | Sep 18, 2009 | clinicaltrials |
| NCT00853684 | Oxaliplatin, Capecitabine and Endostar as First Line Treatment for Patients With Advanced Colorectal Cancer(OXCE) | unknown | Phase 2 | 44 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | Sep 18, 2009 | clinicaltrials |
| NCT00280618 | Oxaliplatin in Unresectable Hepatocellular Carcinoma | completed | Phase 2 | — | SanofiINDUSTRY | 0 | Sep 15, 2009 | clinicaltrials |
| NCT00327119 | Phase 2 Study of ABX-EGF (Panitumumab) in Japanese Subjects With M-colorectal Cancer | completed | Phase 2 | 50 | AmgenINDUSTRY | 0 | Sep 14, 2009 | clinicaltrials |
| NCT00973713 | Study of RAD001 in Advanced Cholangiocarcinoma: RADiChol(RADiChol) | unknown | Phase 2 | 27 | Austin HealthOTHER_GOV | 1 | Sep 9, 2009 | clinicaltrials |
| NCT00972465 | Study of Nimotuzumab to Treat Colorectal Cancer | unknown | Phase 2 | 48 | Peking UniversityOTHER | 1 | Sep 7, 2009 | clinicaltrials |
| NCT00964457 | Treatment of Patients With Advanced Rectum Cancer With Capecitabine and Oxaliplatin Before, Under and After Radiation and With Adding Cetuximab to K-RAS Wild-type Patients | unknown | Phase 2 | 60 | Copenhagen University Hospital at HerlevOTHER | 1 | Aug 25, 2009 | clinicaltrials |
| NCT00496704 | Gemcitabine, Capecitabine, and Oxaliplatin as Second-Line Therapy in Treating Patients With Advanced Colorectal Cancer Previously Treated With Irinotecan | unknown | Phase 1 / Phase 2 | 56 | Yonsei UniversityOTHER | 1 | Aug 21, 2009 | clinicaltrials |
| NCT00961077 | Attenuated SOX as First-line Treatment in Elderly Patients With Relapsed or Metastatic Gastric Cancer | unknown | Phase 2 | 36 | Soonchunhyang University HospitalOTHER | 0 | Aug 18, 2009 | clinicaltrials |
| NCT00495846 | GH, IGF-I and Somatostatin Analogues in Hepatocellular Carcinoma(SS-HCC) | completed | Phase 2 / Phase 3 | 25 | Federico II UniversityOTHER | 1 | Aug 17, 2009 | clinicaltrials |
| NCT00960518 | TACE and Adefovir Compared With Transarterial Chemoembolization (TACE) Alone for Hepatitis B Virus (HBV)-Related Unresectable Hepatocellular Carcinoma (HCC)(TACE) | unknown | Phase 2 | 216 | Tongji UniversityOTHER | 1 | Aug 17, 2009 | clinicaltrials |
| NCT00307723 | Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer | terminated | Phase 1 / Phase 2 | 52 | Massachusetts General HospitalOTHER | 0 | Aug 10, 2009 | clinicaltrials |
Data updated 23 days agoSource updated Feb 5, 2010source: clinicaltrials